Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

被引：50

作者：

Wieduwilt, Matthew J. ^{[1
]}

Metheny, Leland ^{[2
]}

Zhang, Mei-Jie ^{[3
,4
]}

Wang, Hai-Lin ^{[3
]}

Estrada-Merly, Noel ^{[3
]}

Marks, David, I ^{[5
]}

Al-Homsi, A. Samer ^{[6
]}

Muffly, Lori ^{[7
]}

Chao, Nelson ^{[8
]}

Rizzieri, David ^{[9
]}

Gale, Robert Peter ^{[10
]}

Gadalla, Shahinaz M. ^{[11
]}

Cairo, Mitchell ^{[12
]}

Mussetti, Alberto ^{[13
,14
]}

Gore, Steven ^{[15
]}

Bhatt, Vijaya Raj ^{[16
]}

Patel, Sagar S. ^{[17
]}

Michelis, Fotios, V ^{[18
]}

Inamoto, Yoshihiro ^{[19
]}

Badawy, Sherif M. ^{[20
,21
]}

Copelan, Edward ^{[22
]}

Palmisiano, Neil ^{[23
]}

Kharfan-Dabaja, Mohamed A. ^{[24
]}

Lazarus, Hillard M. ^{[25
]}

Ganguly, Siddhartha ^{[26
]}

Bredeson, Christopher ^{[27
]}

Diaz Perez, Miguel Angel ^{[28
]}

Cassaday, Ryan ^{[29
]}

Savani, Bipin N. ^{[30
]}

Ballen, Karen ^{[31
]}

Martino, Rodrigo ^{[32
]}

Wirk, Baldeep ^{[33
]}

Bacher, Ulrike ^{[34
]}

Aljurf, Mahmoud ^{[35
]}

Bashey, Asad ^{[36
]}

Murthy, Hemant S. ^{[24
]}

Yared, Jean A. ^{[37
]}

Aldoss, Ibrahim ^{[38
]}

Farhadfar, Nosha ^{[39
]}

Liu, Hongtao ^{[40
]}

Abdel-Azim, Hisham ^{[41
]}

Waller, Edmund K. ^{[42
]}

Solh, Melhem ^{[43
]}

Seftel, Matthew D. ^{[44
]}

van der Poel, Marjolein ^{[45
]}

Grunwald, Michael R. ^{[22
]}

Liesveld, Jane L. ^{[46
]}

Kamble, Rammurti T. ^{[47
]}

McGuirk, Joseph ^{[26
]}

Munker, Reinhold ^{[48
]}

机构：

[1] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK 73106 USA

[2] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[3] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

[4] Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA

[5] Univ Hosp Bristol Natl Hlth Serv Trust, Adult Bone Marrow Transplant, Bristol, Avon, England

[6] New York Univ Langone Hlth, New York, NY USA

[7] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA

[8] Duke Univ, Med Ctr, Dept Med, Div Cell Therapy & Hematol, Durham, NC 27710 USA

[9] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA

[10] Imperial Coll London, Haematol Res Ctr, Dept Immunol & Inflammat, London, England

[11] NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, NIH, Rockville, MD USA

[12] New York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA

[13] Inst Catala Oncol Hosp, Hematol Dept, Barcelona, Spain

[14] Inst Catala Oncol, Inst Invest Biomed Bellvitge, Lhospitalet De Llobregat, El Prat De Llob, Spain

[15] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA

[16] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[17] Univ Utah, Huntsman Canc Inst, Blood & Marrow Transplant Program, Salt Lake City, UT USA

[18] Princess Margaret Canc Ctr, Allogene Blood & Marrow Transplant Program, Toronto, ON, Canada

[19] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[20] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA

[21] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA

[22] Atrium Hlth, Dept Hematol Oncol & Blood Disorders, Levine Canc Inst, Charlotte, NC USA

[23] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA

[24] Mayo Clin, Blood & Marrow Transplantat Program, Div Hematol Oncol, Jacksonville, FL 32224 USA

[25] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA

[26] Univ Kansas Hlth Syst, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA

[27] Ottawa Hosp, Transplant & Cellular Therapy Program, Ottawa, ON, Canada

[28] Hosp Infantil Univ Nino Jesus, Dept Hematol Oncol, Madrid, Spain

[29] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[30] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA

[31] Univ Virginia Hlth Syst, Div Hematol Oncol, Charlottesville, VA USA

[32] Hosp Santa Creu & Sant Pau, Div Clin Hematol, Barcelona, Spain

[33] Penn State Canc Inst, Bone Marrow Transplant Program, Hershey, PA USA

[34] Univ Bern, Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland

[35] King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia

[36] Northside Hosp, Blood & Marrow Transplant Program, Atlanta, GA USA

[37] Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Blood & Marrow Transplantat Program,Div Hematol O, Baltimore, MD 21201 USA

[38] City Hope Med Ctr, Duarte, CA USA

[39] Univ Florida, Div Hematol Oncol, Coll Med, Gainesville, FL USA

[40] Univ Chicago Med, Sect Hematol Oncol, Chicago, IL USA

[41] Univ Southern Calif, Childrens Hosp Los Angeles, Div Hematol Oncol & Blood & Marrow Transplantat, Keck Sch Med, Los Angeles, CA 90007 USA

[42] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[43] Northside Hosp, Blood & Marrow Transplant Grp Georgia, Atlanta, GA USA

[44] Univ British Columbia, Dept Med, Vancouver, BC, Canada

[45] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[46] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA

[47] Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA

[48] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA

[49] Univ Grenoble Alpes, Ctr Hosp Univ Grenoble Alpes, Dept Hematol, Grenoble, France

[50] Catholic Univ Korea, Div Hematol, Seoul St Marys Hosp, Seoul, South Korea

来源：

BLOOD ADVANCES | 2022年 / 6卷 / 01期

关键词：

MINIMAL RESIDUAL DISEASE; VERSUS-HOST-DISEASE; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; DONOR TRANSPLANTATION; GVHD PROPHYLAXIS; ADULT PATIENTS; RELAPSE; IMPACT; REMISSION; SURVIVAL;

D O I：

10.1182/bloodadvances.2021004916

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We performed a retrospective, multivariable analysis comparing outcomes of HCT approaches by donor for adults with ALL in remission. The primary objective was to compare overall survival (OS) among haploidentical HCTs using PTCy and HLA-matched sibling donor (MSD), 8/8 HLAmatched unrelated donor (MUD), 7 /8 HLA-MUD, or umbilical cord blood (UCB) HCT. Comparing haploidentical HCT to MSD HCT, we found that OS, leukemia-free survival (LFS), nonrelapse mortality (NRM), relapse, and acute graft-versus-host disease (aGVHD) were not different but chronic GVHD (cGVHD) was higher in MSD HCT. Compared with MUD HCT, OS, LFS, and relapse were not different, but MUD HCT had increased NRM (hazard ratio [HR], 1.42; P = .02), grade 3 to 4 aGVHD (HR, 1.59; P = .005), and cGVHD. Compared with 7/8 UD HCT, LFS and relapse were not different, but 7/8 UD HCT had worse OS (HR, 1.38; P = .01) and increased NRM (HR, 2.13; P <_ .001), grade 3 to 4 aGVHD (HR, 1.86; P = .003), and cGVHD (HR, 1.72; P <_ .001). Compared with UCB HCT, late OS, late LFS, relapse, and cGVHD were not different but UCB HCT had worse early OS (<_18 months; HR, 1.93; P < .001), worse early LFS (HR, 1.40; P = .007) and increased incidences of NRM (HR, 2.08; P < .001) and grade 3 to 4 aGVHD (HR, 1.97; P < .001). Haploidentical HCT using PTCy showed no difference in survival but less GVHD compared with traditional MSD and MUD HCT and is the preferred alternative donor HCT option for adults with ALL in complete remission.

引用

页码：339 / 357

页数：19

共 50 条

[1] Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Gu, Bin
Wu, Xiaojin
Chen, Guanghua
Ma, Xiao
Jin, Zhengming
Tang, Xiaowen
Han, Yue
Fu, Chengcheng
Qiu, Huiying
Sun, Aining
Wu, Depei
LEUKEMIA RESEARCH, 2017, 59 : 41 - 46
[2] Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia
Mo, Xiao-Dong
Tang, Bao-Lin
Zhang, Xiao-Hui
Zheng, Chang-Cheng
Xu, Lan-Ping
Zhu, Xiao-Yu
Wang, Yu
Liu, Hui-Lan
Yan, Chen-Hua
Chu, Xian-Deng
Chen, Huan
Geng, Liang-Quan
Liu, Kai-Yan
Sun, Zi-Min
Huang, Xiao-Jun
INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (09) : 2106 - 2115
[3] Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT
Ruggeri, Annalisa
Labopin, Myriam
Savani, Bipin
Paviglianiti, Annalisa
Blaise, Didier
Volt, Fernanda
Ciceri, Fabio
Bacigalupo, Andrea
Tischer, Johanna
Chevallier, Patrice
Koc, Yener
Cornelissen, Jan J.
Ehninger, Gerard
Sanz, Guillermo
Deconinck, Erick
Rocha, Vanderson
Baron, Frederic
Mohty, Mohamad
Gluckman, Eliane
Nagler, Arnon
BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 1987 - 1994
[4] Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT
Shem-Tov, Noga
Peczynski, Christophe
Labopin, Myriam
Itala-Remes, Maija
Blaise, Didier
Labussiere-Wallet, Helene
Socie, Gerard
Kroeger, Nicolaus
Mielke, Stephan
Afanasyev, Boris
Chevallier, Patrice
Tischer, Johanna
Helbig, Grzegorz
Jindra, Pavel
Peric, Zinaida
Giebel, Sebastian
Mohty, Mohamad
Nagler, Arnon
LEUKEMIA, 2020, 34 (01) : 283 - 292
[5] Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
Ruggeri, A.
Labopin, M.
Sanz, G.
Piemontese, S.
Arcese, W.
Bacigalupo, A.
Blaise, D.
Bosi, A.
Huang, H.
Karakasis, D.
Koc, Y.
Michallet, M.
Picardi, A.
Sanz, J.
Santarone, S.
Sengelov, H.
Sierra, J.
Vincent, L.
Volt, F.
Nagler, A.
Gluckman, E.
Ciceri, F.
Rocha, V.
Mohty, M.
LEUKEMIA, 2015, 29 (09) : 1891 - 1900
[6] Hematopoietic Cell Transplantation for Children with Acute Lymphoblastic Leukemia in Second Complete Remission: Similar Outcomes in Recipients of Unrelated Marrow and Umbilical Cord Blood versus Marrow from HLA Matched Sibling Donors
Smith, Angela R.
Baker, K. Scott
DeFor, Todd E.
Verneris, Michael R.
Wagner, John E.
MacMillan, Margaret L.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1086 - 1093
[7] Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?
Champlin, Richard
HAEMATOLOGICA, 2020, 105 (02) : 252 - 254
[8] Unrelated cord blood transplantation with myeloablative conditioning for pediatric acute lymphoblastic leukemia in remission: prognostic factors
Kawahara, Yuta
Morimoto, Akira
Inagaki, Jiro
Koh, Katsuyoshi
Noguchi, Maiko
Goto, Hiroaki
Yoshida, Nao
Cho, Yuko
Hori, Tsukasa
Hiwatari, Mitsuteru
Kato, Keisuke
Ogawa, Atsushi
Hashii, Yoshiko
Inoue, Masami
Kato, Koji
Atsuta, Yoshiko
Kimura, Fumihiko
Kato, Motohiro
BONE MARROW TRANSPLANTATION, 2021, 56 (02) : 357 - 367
[9] Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation
Kawahara, Yuta
Ishimaru, Sae
Tanaka, Junji
Kako, Shinichi
Hirayama, Masahiro
Kanaya, Minoru
Ishida, Hisashi
Sato, Maho
Kobayashi, Ryoji
Kato, Motohiro
Goi, Kumiko
Saito, Shoji
Koga, Yuhki
Hashii, Yoshiko
Kato, Koji
Sato, Atsushi
Atsuta, Yoshiko
Sakaguchi, Hirotoshi
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 598.e1 - 598.e8
[10] Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China
Tang, Xiangfeng
Chen, Jing
Fang, Jianpei
Sun, Xin
Qin, Mao Quan
Li, Junhui
Zhu, Yiping
Luan, Zuo
PEDIATRIC TRANSPLANTATION, 2015, 19 (04) : 413 - 421

← 1 2 3 4 5 →